RESHAPE LIFESCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1645 USD | -0.13% |
|
-1.14% | -34.12% |
| Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
| Apr. 01 | Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024 |
Presentation Operator MessageOperator (Operator)Good afternoon, and thank you for joining the ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Calendar
2024-05-19
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1645
USD
Average target price
1
USD
Spread / Average Target
+507.94%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -34.12% | 3.86M | |
| +5.10% | 213B | |
| +3.60% | 177B | |
| +11.86% | 134B | |
| +16.66% | 99.13B | |
| +0.57% | 63.47B | |
| +16.98% | 53.69B | |
| -4.51% | 46.36B | |
| +0.86% | 41.09B | |
| +11.39% | 39.3B |
- Stock Market
- Equities
- RSLS Stock
- News ReShape Lifesciences Inc.
- Transcript : ReShape Lifesciences Inc., Q2 2022 Earnings Call, Aug 15, 2022
